Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.

Takeda and Bristol Myers Squibb were among the investors that helped the cellular medicine developer close its series B round.

BMW and Ralph Lauren contributed to an $85m round for sustainable materials provider Natural Fiber Welding while Credit Saison invested $80m in virtual credit card service Julo.

Tigermed, Fosun, Haisco and Sinopharm-CICC all scored exits as the oncology and metabolic disorder therapeutics went public in China.

Decentralised finance technology developer BloXroute raised $70m in a round led by SoftBank Vision Fund 2 while Ackermans & van Haaren helped digital health technology developer Medikabazaar score a $700m valuation.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Northwell Health has teamed up with venture studio Aegis Ventures to form a platform which will seed AI-powered healthcare technology developers.

Alcon was among the participants in a round representing the first funding to be disclosed by the cellular ophthalmology therapeutics developer.

Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.

Recombinant protein technology provider Healthgen netted over $87m while shared living space provider Hmlet is buying corporate-backed peer Habyt and Uniswap Labs is launching an investment vehicle.